<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Depression in Children & Young People: Clinical Algorithm</title>
    <style>
        /* --- General Styles & Typography --- */
        :root {
            --primary-color: #005a9c;
            --secondary-color: #3b7ead;
            --accent-color: #d9e8f6;
            --text-color: #333;
            --light-gray: #f4f7f9;
            --border-color: #dce6f0;
            --warning-bg: #fffbe6;
            --warning-border: #ffe58f;
            --danger-color: #d9534f;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol";
            background-color: var(--light-gray);
            color: var(--text-color);
            margin: 0;
            padding: 20px;
            line-height: 1.6;
        }

        /* --- Main Container --- */
        .container {
            max-width: 1100px;
            margin: 20px auto;
            background-color: #fff;
            border-radius: 12px;
            box-shadow: 0 4px 25px rgba(0, 0, 0, 0.07);
            overflow: hidden;
        }

        /* --- Header --- */
        .header {
            background-color: var(--primary-color);
            color: #fff;
            padding: 25px 40px;
            text-align: center;
        }
        .header h1 {
            margin: 0;
            font-size: 2em;
            font-weight: 600;
        }
        .header h2 {
            margin: 5px 0 0;
            font-size: 1.1em;
            font-weight: 300;
            opacity: 0.9;
        }
        
        /* --- Content Area --- */
        .content {
            padding: 30px 40px;
        }

        section {
            margin-bottom: 40px;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 30px;
        }
        section:last-child {
            border-bottom: none;
            margin-bottom: 0;
            padding-bottom: 10px;
        }

        h3 {
            font-size: 1.5em;
            color: var(--primary-color);
            margin-top: 0;
            margin-bottom: 15px;
            font-weight: 600;
            display: flex;
            align-items: center;
        }
        
        h4 {
            font-size: 1.1em;
            color: var(--secondary-color);
            margin-bottom: 10px;
            font-weight: 600;
        }

        /* --- Lists --- */
        ul, ol {
            padding-left: 20px;
        }
        li {
            margin-bottom: 8px;
        }
        li strong {
            color: var(--secondary-color);
        }

        /* --- Section-Specific Styles --- */
        .assessment-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 30px;
        }

        /* --- Management Pathway Table --- */
        .table-wrapper {
            overflow-x: auto; /* For responsiveness */
        }
        
        .management-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 20px;
        }
        .management-table th, .management-table td {
            padding: 15px;
            text-align: left;
            border-bottom: 1px solid var(--border-color);
        }
        .management-table th {
            background-color: var(--accent-color);
            color: var(--primary-color);
            font-weight: 600;
            font-size: 1.1em;
        }
        .management-table tbody tr:hover {
            background-color: #f9fcff;
        }
        .management-table td:first-child {
            font-weight: 700;
            color: var(--primary-color);
            font-size: 1.2em;
            width: 120px;
        }
        .management-table td ul {
            padding-left: 18px;
            margin: 0;
        }
        .management-table td li {
            position: relative;
            padding-left: 20px;
            list-style: none;
        }
        .management-table td li::before {
            content: '‚ñ∂';
            position: absolute;
            left: 0;
            color: var(--secondary-color);
            font-size: 0.8em;
        }

        .warning-note {
            background-color: var(--warning-bg);
            border: 1px solid var(--warning-border);
            border-left: 5px solid #ffc107;
            padding: 12px 18px;
            margin-top: 15px;
            border-radius: 4px;
            font-weight: 500;
        }

        /* --- Prescribing & Referral Section --- */
        .prescribing-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
        }
        .critical-monitoring {
            background-color: var(--accent-color);
            border-left: 5px solid var(--primary-color);
            padding: 12px 18px;
            border-radius: 4px;
        }
        .meds-avoid {
            color: var(--danger-color);
            font-weight: 700;
        }
        .referral-box {
            background-color: #fff9f9;
            border: 1px solid #ffe1e1;
            border-left: 5px solid var(--danger-color);
            padding: 20px;
            border-radius: 8px;
        }

        /* --- Footer --- */
        footer {
            text-align: center;
            padding: 20px;
            font-size: 0.85em;
            color: #888;
        }

        /* --- Responsive Adjustments --- */
        @media (max-width: 900px) {
            .prescribing-grid {
                grid-template-columns: 1fr;
            }
        }
        @media (max-width: 768px) {
            body { padding: 10px; }
            .content { padding: 20px; }
            .header { padding: 20px; }
            .header h1 { font-size: 1.8em; }
            .header h2 { font-size: 1em; }
            .assessment-grid { grid-template-columns: 1fr; }
        }
    </style>
</head>
<body>

    <div class="container">
        <header class="header">
            <h1>Depression in Children & Young People</h1>
            <h2>A Quick Reference Clinical Algorithm (Ages 5-18)</h2>
        </header>

        <main class="content">
            <!-- Section 1: Assessment & Diagnosis -->
            <section id="assessment">
                <h3>1. Assessment & Diagnosis</h3>
                <div class="assessment-grid">
                    <div>
                        <h4>Suspect Depression If Core Symptoms Present:</h4>
                        <ul>
                            <li>Persistent sadness, low mood, or <strong>irritability</strong>.</li>
                            <li>Marked loss of interest or pleasure (<strong>anhedonia</strong>).</li>
                        </ul>
                    </div>
                    <div>
                        <h4>Diagnostic Assessment Steps:</h4>
                        <ol>
                            <li><strong>Take History:</strong> Inquire about symptoms, duration, and functional impact.</li>
                            <li><strong>Identify Risk Factors:</strong> Family history, life events, trauma, etc.</li>
                            <li><strong>Screen for Comorbidities:</strong> Anxiety, neurodiversity, substance use.</li>
                            <li><strong>Rule Out Organic Causes:</strong> Consider tests if indicated (e.g., anaemia).</li>
                        </ol>
                    </div>
                    <div>
                        <h4>Diagnostic Criteria (ICD-11):</h4>
                        <ul>
                            <li><strong>‚â•5 symptoms</strong> present most of the day, nearly every day, for <strong>at least 2 weeks</strong>.</li>
                            <li>Must include at least one core symptom.</li>
                            <li>Causes <strong>significant functional impairment</strong>.</li>
                        </ul>
                    </div>
                    <div>
                        <h4>Associated Symptoms:</h4>
                        <ul>
                            <li>Reduced concentration/indecisiveness</li>
                            <li>Low self-esteem/guilt</li>
                            <li>Hopelessness / Suicidal thoughts</li>
                            <li>Disturbed sleep & appetite</li>
                            <li>Fatigue / Psychomotor changes</li>
                        </ul>
                    </div>
                </div>
            </section>

            <!-- Section 2: Severity Assessment & Management -->
            <section id="management">
                <h3>2. Severity Assessment & Management Pathway</h3>
                <div class="table-wrapper">
                    <table class="management-table">
                        <thead>
                            <tr>
                                <th>Severity</th>
                                <th>Guidance</th>
                                <th>Management Pathway</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>MILD</td>
                                <td>None of the symptoms are intense. Some difficulty with functioning.</td>
                                <td>
                                    <ul>
                                        <li><strong>Step 1: Watchful Waiting & Support</strong><br>Provide lifestyle advice (sleep, diet, exercise). Arrange follow-up in <strong>2 weeks</strong>.</li>
                                        <li><strong>Step 2 (If No Improvement): Psychological Intervention</strong><br>Offer digital CBT, group CBT, or non-directive supportive therapy.</li>
                                        <li><strong>Step 3 (If No Response after 2-3 months):</strong><br><strong>Refer to CAMHS.</strong></li>
                                    </ul>
                                    <div class="warning-note">‚ö†Ô∏è Do NOT use antidepressants for initial treatment of mild depression.</div>
                                </td>
                            </tr>
                            <tr>
                                <td>MODERATE</td>
                                <td>Several symptoms are marked, OR many symptoms of lesser severity are present. Considerable difficulty functioning.</td>
                                <td rowspan="2">
                                     <ul>
                                        <li><strong>Step 1: Refer to CAMHS</strong><br>All cases require review by a Child & Adolescent Mental Health Services team.</li>
                                        <li><strong>Step 2: Psychological Intervention (First-Line)</strong><br>Offer high-intensity therapy (e.g., individual CBT, family therapy).</li>
                                        <li><strong>Step 3 (If No Response after 4-6 Sessions): Multidisciplinary Review</strong><br>Re-evaluate and consider coexisting factors.</li>
                                        <li><strong>Step 4 (Post-Review): Consider Combination Treatment</strong><br>Add <strong>Fluoxetine</strong> to ongoing psychological therapy.</li>
                                    </ul>
                                </td>
                            </tr>
                            <tr>
                                <td>SEVERE</td>
                                <td>Most symptoms are marked/intense. Serious difficulty functioning in most domains.</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </section>

            <!-- Section 3: Prescribing & Referral -->
            <section id="prescribing-referral">
                <h3>3. Key Prescribing & Referral Information</h3>
                <div class="prescribing-grid">
                    <div>
                        <h4>Fluoxetine Prescribing Principles</h4>
                        <ul>
                            <li><strong>Prerequisites:</strong> Must be prescribed by a child/adolescent psychiatrist & combined with psychological therapy.</li>
                            <li><strong>Starting Dose:</strong> 10 mg daily (may increase to 20 mg after 1 week).</li>
                            <li class="critical-monitoring"><strong>Critical Monitoring:</strong> Review <strong>weekly for the first 4 weeks</strong>. Monitor for increased suicidal ideation, self-harm, or hostility.</li>
                            <li><strong>Duration:</strong> Continue for at least <strong>6 months after remission</strong>.</li>
                            <li><strong>Discontinuation:</strong> Taper dose gradually over 6-12 weeks.</li>
                            <li><strong>Medications to <span class="meds-avoid">AVOID</span>:</strong> Paroxetine, Venlafaxine, TCAs, St. John's Wort.</li>
                        </ul>
                    </div>
                    <div class="referral-box">
                        <h4>üö® Immediate & Urgent Referral Criteria</h4>
                        <p>Refer urgently to CAMHS if the child or young person has:</p>
                        <ul>
                            <li>Active suicidal ideas or a plan.</li>
                            <li>Psychotic symptoms (delusions or hallucinations).</li>
                            <li>Moderate to severe depression.</li>
                            <li>High and recurrent risk of self-harm.</li>
                            <li>Significant self-neglect harmful to physical health.</li>
                            <li>Mild depression unresponsive to primary care interventions.</li>
                        </ul>
                    </div>
                </div>
            </section>
        </main>
    </div>

    <footer>
        This algorithm is a summary based on the NICE CKS topic "Depression in children" (last revised March 2025). It does not replace clinical judgment.
    </footer>

</body>
</html>